Group A meningococcal polysaccharide vaccine

BIOLOGICAL2 trials

Sponsors

Jiangsu Province Centers for Disease Control and Prevention

Conditions

Hand, Foot and Mouth DiseaseHepatitis A

Phase 4

Immunogenicity and Safety of Inactivated and Live Attenuated Hepatitis A Vaccines

CompletedNCT02601040

Jiangsu Province Centers for Disease Control and PreventionHepatitis A

Start: 2011-11-30End: 2015-10-31Updated: 2015-11-10

Immunogenicity of the Inactivated EV71 Vaccine Combined With Hepatitis B and Group A Meningococcal Vaccine

Active, not recruitingNCT06209398

Jiangsu Province Centers for Disease Control and PreventionHand, Foot and Mouth Disease

Start: 2018-05-24End: 2025-12-31Updated: 2024-01-17

Related Papers

The Safety, Immunogenicity, and Immunopersistence of Hepatitis A Vaccine in HBs-Ag-Positive Participants: A Retrospective Study

Frontiers in Cellular and Infection Microbiology2021-06-17

Long-term immunogenicity and immune persistence of live attenuated and inactivated hepatitis a vaccines: a report on additional observations from a phase IV study.

2018-11-278 citations